Science Explorer Back to mapMap

Most cited papers from West Texas Retina Consultants

What are the most cited papers from West Texas Retina Consultants?

The most cited paper from West Texas Retina Consultants is "Ranibizumab for Diabetic Macular Edema" (Quan Dong Nguyen, David M. Brown, Dennis M. Marcus et al., 2012), with 1,625 citations. Next come "Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials" (831) and "C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration" (474).

Showing 39 of 39 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Ranibizumab for Diabetic Macular Edema Quan Dong Nguyen, David M. Brown, Dennis M. Marcus et al. · Ophthalmology 11 Feb 2012 1,625
2 Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials David M. Brown, Quan Dong Nguyen, Dennis M. Marcus et al. · Ophthalmology Open access 22 May 2013 831
3 C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration Glenn J. Jaffe, Keith Westby, Karl G. Csaky et al. · Ophthalmology Open access Sep 2020 474
4 Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial Arshad M. Khanani et al. · The Lancet Open access226 authors 8 Sep 2023 364
5 Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema Jayashree Sahni, Sunil S. Patel, Pravin U. Dugel et al. · Ophthalmology Open access 21 Mar 2019 290
6 Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration Arshad M. Khanani, Sunil S. Patel, Philip J. Ferrone et al. · JAMA Ophthalmology Open access 30 Jul 2020 185
7 Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial Sunil S. Patel, David R. Lally, Jason Hsu et al. · Eye Open access 24 Mar 2023 144
8 Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration Jayashree Sahni, Pravin U. Dugel, Sunil S. Patel et al. · JAMA Ophthalmology Open access 30 Jul 2020 130
9 A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema David Callanan, Anat Loewenstein, Sunil S. Patel et al. · Graefe s Archive for Clinical and Experimental Ophthalmology 8 Sep 2016 106
10 Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration David Callanan, Derek Y. Kunimoto, Raj K. Maturi et al. · Journal of Ocular Pharmacology and Therapeutics Open access 9 Nov 2018 74
11 PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF BRIMONIDINE DRUG DELIVERY SYSTEM (BRIMO DDS) GENERATION 1 IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION Baruch D. Kuppermann, Sunil S. Patel, David S. Boyer et al. · Retina Open access 3 Mar 2020 66
12 Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema Mark Barakat, Charles C. Wykoff, Víctor H. González et al. · Ophthalmology Retina Open access 20 Aug 2020 57
13 Classification of dementia patients by a WAIS profile related to central cholinergic deficiencies Samuel D. Brinkman, P Braun · Journal of Clinical and Experimental Neuropsychology Nov 1984 51
14 EPIRETINAL MACULAR MEMBRANES IN EYES WITH ATTACHED POSTERIOR CORTICAL VITREOUS Todd W. Heilskov, Stephen J. Massicotte, James C. Folk · Retina 1996 40
15 Randomized Phase IIb Study of Brimonidine Drug Delivery System Generation 2 for Geographic Atrophy in Age-Related Macular Degeneration William R. Freeman et al. · Ophthalmology Retina Open access 9 Mar 2023 25
16 Utility Measures of Health-Related Quality of Life in Patients Treated for Benign Paroxysmal Positional Vertigo Richard A. Roberts, Harvey B. Abrams, Melanie K. Sembach et al. · Ear and Hearing 21 May 2009 23
17 Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular Degeneration Sunil S. Patel, Philip P. Storey, Mark Barakat et al. · Ophthalmology Science Open access 9 Apr 2024 19
18 Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy Yasir Jamal Sepah et al. · Eye Open access129 authors 15 Apr 2024 16
19 Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results David Callanan, Rahul N. Khurana, Raj K. Maturi et al. · Clinical ophthalmology Open access May 2023 12
20 Multiple Evanescent White Dot Syndrome Developing Three Days following Administration of mRNA-1273 Booster Vaccine: Case Report Rashed Alhabshan, David A. Scales · Case Reports in Ophthalmology Open access 18 Jul 2022 10
21 PALEOECOLOGY OF THE GADDIS SITE IN THE UPPER CRETACEOUS AGUJA FORMATION, TERLINGUA, TEXAS Homer Montgomery, Scott Clark · Palaios Jul 2016 9
22 Patient-, Caregiver-, and Eye Care Professional-reported Burden of Geographic Atrophy Secondary to Age-related Macular Degeneration Rishi P. Singh, Sunil S. Patel, Jared S. Nielsen et al. · American Journal of Ophthalmic Clinical Trials Open access 5 Apr 2019 8
23 Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration Arshad M. Khanani et al. · Ophthalmology Open access219 authors 16 Dec 2025 7
24 Randomized Trials Comparing Inferior Turbinoplasty Techniques for Nasal Obstruction: A Meta‐analysis Macario Camacho, Yoseph A. Kram, Forrest D. Craig et al. · Otolaryngology Open access 9 May 2025 5
25 Safety and tolerability of avacincaptad pegol in combination with ranibizumab in treatment-naïve patients with neovascular age-related macular degeneration: results from a phase 1 and phase 2a study Sunil S Patel, David S Boyer, Anat Loewenstein et al. · BMJ Open Ophthalmology Open access 3 Feb 2026 1
26 ONL1204 for the Treatment of Geographic Atrophy: Phase Ib Study Evaluating Safety, Tolerability, and Efficacy David M Kleinman, Charles C. Wykoff, Durga S. Borkar et al. · Ophthalmology Science Open access 4 Oct 2025 1
27 Automated Deep Learning-Based 3D-to-2D Segmentation of Geographic Atrophy in Optical Coherence Tomography Data Hasenin Al-khersan, Jonathan D. Oakley, Daniel B. Russakoff et al. · medRxiv PreprintOpen access 7 Jul 2025 1
28 Anti-VEGF/anti-angiopoietin-2 bispecific antibody RG7716 in diabetic macular edema: complete 36-week results from the phase 2, multicenter, randomized, active treatment-controlled BOULEVARD clinical trial Sunil S. Patel, Jayashree Sahni, Shamil Sadikhov et al. · Investigative Ophthalmology & Visual Science Open access 13 Jul 2018 1
29 Primary Retinal Vasculitis Vs Eales' Disease Courtney M. Crawford · International Journal of open Access Ophthalmology Open access 30 Sep 2016 1
30 Cost Analysis of Aflibercept 8 mg Versus Aflibercept 2 mg for the Treatment of Diabetic Macular Edema in the PHOTON Trial Céline Chaaya, Stephanie Zhang, Samantha E. Hoffman et al. · Journal of VitreoRetinal Diseases Open access 21 Jul 2026 0
31 A randomized, active-controlled clinical trial of fluocinolone acetonide 0.19 mg intravitreal implant for diabetic macular edema: Reductions in injection treatment burden – results from the NEW DAY study Christopher D. Riemann, Michael Singer, Charles C. Wykoff et al. · German Medical Science (German Research Foundation) Conference paperOpen access 17 Jun 2026 0
32 Safety and Biological Activity of Intravitreal OGX110, a CXCR3 Agonist, in Persistent Neovascular Age-Related Macular Degeneration: A Phase I Dose-Escalation Study Alan Wells, David Boyer, Roger Goldberg et al. · medRxiv PreprintOpen access 30 May 2026 0
33 Biomarker Testing Rates and Patterns in Patients With Metastatic Non–Small Cell Lung Cancer: A Prospective, Observational Study in Community Practices Makenzi Evangelist, Bo Wang, James E. Butrynski et al. · JCO Precision Oncology Open access Apr 2026 0
34 Unit-Dose IPPB Medications W H Harbour · Respiratory Care Feb 1974 0
35 OphthoEvidence report: Protocol for quality appraisal of clinical practice guidelines in ophthalmology João Pedro Lima, Md. Nazmul Islam, Hamed Movahed et al. · Eye Open access 10 Feb 2026 0
36 MAGIC: Study Design and Rationale for the Phase 2 Clinical Trial of Faricimab for Non-Proliferative Diabetic Retinopathy Avery Zhou et al. · Ophthalmologica Open access 26 Jan 2026 0
37 Updated Surgical Technique for Implantation of Revakinagene Taroretcel Gail M. Teagle, Avery Zhou, Thomas M. Aaberg et al. · Retina 8 Oct 2025 0
38 RISK OF IATROGENIC PERIPHERAL RETINAL BREAKS IN 20-G PARS PLANA VITRECTOMY G. Janzen, Elias Reichel · Evidence-Based Ophthalmology Jul 2011 0
39 Patient-, caregiver-, and healthcare provider-reported burden of geographic atrophy Sunil S. Patel, Rishi P. Singh, Jared S. Nielsen et al. · Investigative Ophthalmology & Visual Science Open access 23 Jun 2017 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.